Witnessing the stock’s movement on the chart, on Thursday, Athira Pharma Inc (NASDAQ: ATHA) had a quiet start as it plunged -4.68% to $0.43, before settling in for the price of $0.45 at the close. Taking a more long-term approach, ATHA posted a 52-week range of $0.41-$4.30.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare sector firm’s twelve-monthly sales growth has been 0.00% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was -81.69%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 16.56%. This publicly-traded company’s shares outstanding now amounts to $38.17 million, simultaneously with a float of $35.41 million. The organization now has a market capitalization sitting at $16.45 million. At the time of writing, stock’s 50-day Moving Average stood at $0.8962, while the 200-day Moving Average is $2.3482.
Athira Pharma Inc (ATHA) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. Athira Pharma Inc’s current insider ownership accounts for 7.89%, in contrast to 58.01% institutional ownership. Preceding that transaction, on Sep 05 ’24, Company’s CFO and Chief Business Officer sold 1,272 for 0.57, making the whole transaction’s value amount to 720. This particular insider is now the holder of 97,532 in total.
Athira Pharma Inc (ATHA) Earnings and Revenue Records
Athira Pharma Inc’s EPS increase for this current 12-month fiscal period is 16.56% and is forecasted to reach -1.63 in the upcoming year.
Athira Pharma Inc (NASDAQ: ATHA) Trading Performance Indicators
Let’s observe the current performance indicators for Athira Pharma Inc (ATHA). It’s Quick Ratio in the last reported quarter now stands at 3.97. The Stock has managed to achieve an average true range (ATR) of 0.06.
In the same vein, ATHA’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.97, a figure that is expected to reach -0.70 in the next quarter, and analysts are predicting that it will be -1.63 at the market close of one year from today.
Technical Analysis of Athira Pharma Inc (ATHA)
Going through the that latest performance of [Athira Pharma Inc, ATHA]. Its last 5-days volume of 1.62 million indicated improvement to the volume of 0.48 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 15.44% While, its Average True Range was 0.0459.
Raw Stochastic average of Athira Pharma Inc (ATHA) in the period of the previous 100 days is set at 0.51%, which indicates a major fall in contrast to 9.15% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 95.35% that was lower than 255.52% volatility it exhibited in the past 100-days period.
